| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Knight Jeff E. is a Chief Operating Officer at CRNX. Recent filings cover 0 purchases and 8 sales.
Our model assigns Knight Jeff E. a middling insider score of 68/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +20.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sell10b5-1 | 7,162 | $34.20 | $244,963.80 | -7.6% | -11.0% | +3.3% | |
| Nov 22, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sell10b5-1 | 501 | $56.52 | $28,316.52 | -1.0% | -34.2% | -23.5% | |
| Jul 15, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 27,000 | $55.00 | $1,485,000.00 | -34.3% | -1.9% | -41.2% | |
| Jun 26, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sell10b5-1 | 956 | $44.38 | $42,427.28 | -1.8% | +18.1% | -28.9% | |
| Mar 22, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 32,359 | $44.31 | $1,433,675.01 | -38.1% | -0.2% | -22.3% | |
| Jul 26, 2022 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 1,152 | $20.70 | $23,846.86 | -18.9% | -17.3% | -8.2% |